Sadly, my hairline is receding, so my interest was easily piqued when I came across Intercytex (LSE: ICX), a small UK biotech which is developing a promising treatment for hair loss.
The treatment is called ICX-TRC and is similar in some ways to conventional hair transplants. Current procedures involve taking hair from the back of man’s head and transplanting it to the man’s bald patches. This process leaves a gap on the back of the head, so the gap is then drawn together….
Continue reading this article at the Motley Fool